Skip to menu Skip to content Skip to footer

2004

Journal Article

Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection

McKay, Fiona C., McArthur, Jason D., Sanderson-Smith, Marina L., Gardam, Sandra, Currie, Bart J., Sriprakash, Kadaba S., Fagan, Peter K., Towers, Rebecca J., Batzloff, Michael R., Chhatwal, Gursharan S., Ranson, Marie and Walker, Mark J. (2004). Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection. Infection and Immunity, 72 (1), 364-370. doi: 10.1128/IAI.72.1.364-370.2004

Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection

2003

Journal Article

Evolution of sfbI encoding streptococcal fibronectin-binding protein I: Horizontal genetic transfer and gene mosaic structure

Towers, R. J., Fagan, P. K., Talay, S. R., Currie, B. J., Sriprakash, K. S., Walker, M. J. and Chhatwal, G. S. (2003). Evolution of sfbI encoding streptococcal fibronectin-binding protein I: Horizontal genetic transfer and gene mosaic structure. Journal of Clinical Microbiology, 41 (12), 5398-5406. doi: 10.1128/JCM.41.12.5398-5406.2003

Evolution of sfbI encoding streptococcal fibronectin-binding protein I: Horizontal genetic transfer and gene mosaic structure

2003

Journal Article

Distribution of intimin subtypes among Escherichia coli isolates from ruminant and human sources

Ramachandran, V., Brett, K., Hornitzky, M. A., Dowton, M., Bettelheim, K. A., Walker, M. J. and Djordjevic, S. P. (2003). Distribution of intimin subtypes among Escherichia coli isolates from ruminant and human sources. Journal of Clinical Microbiology, 41 (11), 5022-5032. doi: 10.1128/JCM.41.11.5022-5032.2003

Distribution of intimin subtypes among Escherichia coli isolates from ruminant and human sources

2003

Journal Article

The pyruvate dehydrogenase complex of Mycoplasma hyopneumoniae contains a novel lipoyl domain arrangement

Matic, JN, Wilton, JL, Towers, RJ, Scarman, AL, Minion, FC, Walker, MJ and Djordjevic, SP (2003). The pyruvate dehydrogenase complex of Mycoplasma hyopneumoniae contains a novel lipoyl domain arrangement. Gene, 319, 99-106. doi: 10.1016/S0378-1119(03)000798-4

The pyruvate dehydrogenase complex of Mycoplasma hyopneumoniae contains a novel lipoyl domain arrangement

2003

Journal Article

Asp(274) and His(346) are essential for heme binding and catalytic function of human indoleamine 2,3-dioxygenase

Littlejohn, TK, Takikawa, O, Truscott, RJW and Walker, MJ (2003). Asp(274) and His(346) are essential for heme binding and catalytic function of human indoleamine 2,3-dioxygenase. Journal of Biological Chemistry, 278 (32), 29525-29531. doi: 10.1074/jbc.M301700200

Asp(274) and His(346) are essential for heme binding and catalytic function of human indoleamine 2,3-dioxygenase

2003

Journal Article

Bovine non-O157 Shiga toxin 2-containing Escherichia coli isolates commonly possess stx(2-EDL933) and/or stx(2vhb) subtypes

Brett, K. N., Hornitzky, M. A., Bettelheim, K. A., Walker, M. J. and Djordjevic, S. P. (2003). Bovine non-O157 Shiga toxin 2-containing Escherichia coli isolates commonly possess stx(2-EDL933) and/or stx(2vhb) subtypes. Journal of Clinical Microbiology, 41 (6), 2716-2722. doi: 10.1128/JCM.41.6.2716-2722.2003

Bovine non-O157 Shiga toxin 2-containing Escherichia coli isolates commonly possess stx(2-EDL933) and/or stx(2vhb) subtypes

2003

Journal Article

A model for predicting likely sites of CYP3A4-mediated metabolism on drug-like molecules

Singh, SB, Shen, LQ, Walker, MJ and Sheridan, RP (2003). A model for predicting likely sites of CYP3A4-mediated metabolism on drug-like molecules. Journal of Medicinal Chemistry, 46 (8), 1330-1336. doi: 10.1021/jm020400s

A model for predicting likely sites of CYP3A4-mediated metabolism on drug-like molecules

2003

Journal Article

An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection

McArthur, JD, West, NP, Cole, JN, Jungnitz, H, Guzman, CA, Chin, J, Lehrbach, PR, Djordjevic, SP and Walker, MJ (2003). An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection. Fems Microbiology Letters, 221 (1), 7-16. doi: 10.1016/S0378-1097(03)00162-9

An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection

2003

Journal Article

stx(1c) is the most common Shiga toxin 1 subtype among Shiga toxin-producing Escherichia coli isolates from sheep but not among isolates from cattle

Brett, K. N., Ramachandran, V., Hornitzky, M. A., Bettelheim, K. A., Walker, M. J. and Djordjevic, S. P. (2003). stx(1c) is the most common Shiga toxin 1 subtype among Shiga toxin-producing Escherichia coli isolates from sheep but not among isolates from cattle. Journal of Clinical Microbiology, 41 (3), 926-936. doi: 10.1128/JCM.41.3.926-936.2003

stx(1c) is the most common Shiga toxin 1 subtype among Shiga toxin-producing Escherichia coli isolates from sheep but not among isolates from cattle

2002

Journal Article

CKB - The Compound Knowledge Base: A text based chemical search system

Walker, MJ, Hull, RD and Singh, SB (2002). CKB - The Compound Knowledge Base: A text based chemical search system. Journal of Chemical Information and Computer Sciences, 42 (6), 1293-1295. doi: 10.1021/ci0255329

CKB - The Compound Knowledge Base: A text based chemical search system

2002

Journal Article

Production of truncated enzymically active human indoleamine 2,3-dioxygenase using site-directed mutagenesis

Littlejohn, Tamantha K., Takikawa, Osamu, Jamie, Joanne F., Walker, Mark J. and Truscott, Roger J.W (2002). Production of truncated enzymically active human indoleamine 2,3-dioxygenase using site-directed mutagenesis. International Congress Series, 1233 (C), 157-160. doi: 10.1016/S0531-5131(02)00312-6

Production of truncated enzymically active human indoleamine 2,3-dioxygenase using site-directed mutagenesis

2002

Journal Article

Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci

Erdogan, Sezgin, Fagan, Peter K., Talay, Susanne R., Rohde, Manfred, Ferrieri, Patricia, Flores, Aurea E., Guzman, Carlos A., Walker, Mark J. and Chhatwal, Gursharan S. (2002). Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci. Infection and Immunity, 70 (2), 803-811. doi: 10.1128/IAI.70.2.803-811.2002

Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci

2002

Journal Article

Antiarrhythmic drug development - Illusion and disillusion?

Walker, MJA (2002). Antiarrhythmic drug development - Illusion and disillusion?. Drug Development Research, 55 (1), 1-2. doi: 10.1002/ddr.10035

Antiarrhythmic drug development - Illusion and disillusion?

2002

Journal Article

Streptococcus pyogenes prtFII, but not sfbI, sfbII or fbp54, is represented more frequently among invasive-disease isolates of tropical Australia

Delvecchio, A., Currie, B. J., McArthur, J. D., Walker, M. J. and Sriprakash, K. S. (2002). Streptococcus pyogenes prtFII, but not sfbI, sfbII or fbp54, is represented more frequently among invasive-disease isolates of tropical Australia. Epidemiology and Infection, 128 (3), 391-396. doi: 10.1017/S0950268802006787

Streptococcus pyogenes prtFII, but not sfbI, sfbII or fbp54, is represented more frequently among invasive-disease isolates of tropical Australia

2002

Journal Article

Immunological response mounted by Aboriginal Australians living in the Northern Territory of Australia against Streptococcus pyogenes serum opacity factor

Gillen, Christine M., Towers, Rebecca J., McMillan, David J., Delvecchio, Armando, Sriprakash, Kadaba S., Currie, Bart, Kreikemeyer, Berndt, Chhatwal, Gurusharan S. and Walker, Mark J. (2002). Immunological response mounted by Aboriginal Australians living in the Northern Territory of Australia against Streptococcus pyogenes serum opacity factor. Microbiology, 148 (1), 169-178. doi: 10.1099/00221287-148-1-169

Immunological response mounted by Aboriginal Australians living in the Northern Territory of Australia against Streptococcus pyogenes serum opacity factor

2001

Journal Article

The common ovine shiga toxin 2-containing Escherichia coli serotypes and human isolates of the same serotypes possess a Stx2d toxin type

Ramachandran, V., Hornitzky, M. A., Bettelheim, K. A., Walker, M. J. and Djordjevic, S. P. (2001). The common ovine shiga toxin 2-containing Escherichia coli serotypes and human isolates of the same serotypes possess a Stx2d toxin type. Journal of Clinical Microbiology, 39 (5), 1932-1937. doi: 10.1128/JCM.39.5.1932-1937.2001

The common ovine shiga toxin 2-containing Escherichia coli serotypes and human isolates of the same serotypes possess a Stx2d toxin type

2001

Journal Article

The virulence factors of Bordetella pertussis: a matter of control

Smith, AM, Guzman, CA and Walker, MJ (2001). The virulence factors of Bordetella pertussis: a matter of control. Fems Microbiology Reviews, 25 (3), 309-333. doi: 10.1111/j.1574-6976.2001.tb00580.x

The virulence factors of Bordetella pertussis: a matter of control

2001

Journal Article

Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs

Fagan, PK, Walker, MJ, Chin, J, Eamens, GJ and Djordjevic, SP (2001). Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs. Microbial Pathogenesis, 30 (2), 101-110. doi: 10.1006/mpat.2000.0412

Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs

2000

Journal Article

Co-expression of the Bordetella pertussis leader peptidase I results in enhanced processing and expression of the pertussis toxin S1 subunit in Escherichia coli

Smith, AM, Yan, H, Groves, N, Dalla Pozza, T and Walker, MJ (2000). Co-expression of the Bordetella pertussis leader peptidase I results in enhanced processing and expression of the pertussis toxin S1 subunit in Escherichia coli. Fems Microbiology Letters, 191 (2), 177-182. doi: 10.1016/S0378-1097(00)00386-4

Co-expression of the Bordetella pertussis leader peptidase I results in enhanced processing and expression of the pertussis toxin S1 subunit in Escherichia coli

2000

Journal Article

Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence

West, Nicholas P., Jungnitz, Heidrun, Fitter, John T., McArthur, Jason D., Guzman, Carlos A. and Walker, Mark J. (2000). Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infection and Immunity, 68 (8), 4673-4680. doi: 10.1128/IAI.68.8.4673-4680.2000

Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence